James is a physician, patent attorney, and partner at FisherBroyles, where he practices patent litigation and prosecution in the areas of medical devices, biotechnology, software, and pharmaceuticals. He is a cofounder of Highpoint Therapeutics, an oncology startup focused on killing cancer stem cells with nanoencapsulated salinomycin and other agents.
A graduate of the University of Southern California (USC) School of Medicine, James received residency training in internal medicine and in radiology at the Massachusetts General Hospital and Harvard Medical School, where he was awarded a fellowship in neuroradiology. He completed coursework in the Master of Science in Electrical Engineering program at USC, with an emphasis in signal and image processing. He is a member of the American Society for Clinical Nutrition with a research interest in Alzheimer’s disease and other neurodegenerative diseases.
James is recommended in Chambers USA and The Legal 500 United States in the area of life sciences and named a leading patent professional in California by IAM Patent 1000 – The World’s Leading Patent Practitioners for both patent litigation and prosecution, and a Top 25 Portfolio Manager by the Daily Journal. He has served on the scientific board of advisors for several life science companies.